176 related articles for article (PubMed ID: 33269614)
1. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis.
Luo X; Yu B; Jiang N; Du Q; Ye X; Li H; Wang WQ; Zhai Q
Cancer Control; 2020; 27(1):1073274820977135. PubMed ID: 33269614
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis.
Tsujita E; Ikeda Y; Kinjo N; Yamashita YI; Hisano T; Furukawa M; Taguchi KI; Morita M; Toh Y; Okamura T
Am Surg; 2017 Jun; 83(6):610-616. PubMed ID: 28637563
[TBL] [Abstract][Full Text] [Related]
4. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.
Luo G; Guo M; Liu Z; Xiao Z; Jin K; Long J; Liu L; Liu C; Xu J; Ni Q; Yu X
Ann Surg Oncol; 2015 Feb; 22(2):670-6. PubMed ID: 25155401
[TBL] [Abstract][Full Text] [Related]
5. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
Alagappan M; Pollom EL; von Eyben R; Kozak MM; Aggarwal S; Poultsides GA; Koong AC; Chang DT
Am J Clin Oncol; 2018 Mar; 41(3):242-247. PubMed ID: 26757436
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.
Powell AGMT; Chin C; Coxon AH; Chalishazar A; Christian A; Roberts SA; Lewis WG
BJS Open; 2020 Jun; 4(3):416-423. PubMed ID: 32232963
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.
McLellan P; Henriques J; Ksontini F; Doat S; Hammel P; Desrame J; Trouilloud I; Louvet C; Pietrasz D; Vernerey D; Bachet JB
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101541. PubMed ID: 33055007
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis.
Zou P; Yang E; Li Z
Sci Rep; 2020 Dec; 10(1):21917. PubMed ID: 33318608
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.
Cheng H; Long F; Jaiswar M; Yang L; Wang C; Zhou Z
Sci Rep; 2015 Jul; 5():11026. PubMed ID: 26226887
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
11. The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer.
Shusterman M; Jou E; Kaubisch A; Chuy JW; Rajdev L; Aparo S; Tang J; Ohri N; Negassa A; Goel S
J Gastrointest Cancer; 2020 Sep; 51(3):868-876. PubMed ID: 31677056
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of neutrophil-to-lymphocyte ratio in melanoma: Evidence from a PRISMA-compliant meta-analysis.
Ding Y; Zhang S; Qiao J
Medicine (Baltimore); 2018 Jul; 97(30):e11446. PubMed ID: 30045267
[TBL] [Abstract][Full Text] [Related]
13. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma.
Sugiura T; Uesaka K; Kanemoto H; Mizuno T; Okamura Y
Ann Surg Oncol; 2013 Dec; 20(13):4330-7. PubMed ID: 23982254
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
15. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
[TBL] [Abstract][Full Text] [Related]
16. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S
Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study.
Bozkurt O; Firat ST; Dogan E; Cosar R; Inanc M; Ozkan M
J BUON; 2019; 24(5):1992-1999. PubMed ID: 31786866
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
Formica V; Morelli C; Ferroni P; Nardecchia A; Tesauro M; Pellicori S; Cereda V; Russo A; Riondino S; Guadagni F; Roselli M
Cancer Biomark; 2016 Sep; 17(3):335-345. PubMed ID: 27434293
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
